SBIR-STTR Award

Development Of Optical Device For Use In Drug Discovery
Award last edited on: 5/7/02

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$97,423
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Jesse Baumgold

Company Information

Receptor Biology Inc

5202 Westland Boulevard
Baltimore, MD 21227
   (410) 455-6881
   contact@receptorbiology.com
   www.receptorbiology.com
Location: Single
Congr. District: 03
County: Baltimore

Phase I

Contract Number: 1R43NS036516-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1998
Phase I Amount
$97,423
This proposal addresses the Molecular Neurobiology interest of NINDS from the latest Omnibus solicitation. A high throughput, fluorescence based technique to measure receptor mediated cellular responses is proposed. The goal is to develop an optical probe capable of measuring intracellular Ca2+ signals reported by fluorescent dyes for high volume application such as screening a number of synthetic or natural compounds. A number of reporter dyes are now available to measure intracellular Ca2+ signals following surface membrane receptor activation and methods exist to test if these signals are transduced by inotropic or metabotropic mechanisms. The optical probe design will incorporate efficient light throughput, cell perfusion and fast data acquisition. The commercial application of the development is that a rapid, inexpensive and quantitative assay will become available to be offered as a contract service by Receptor Biology to pharmaceutical companies, government and universities to screen novel synthetic and naturally occurring compounds in the search for novel neuro-active pharmaceuticals. The major advantage of the method include: 1) independence from radioisotopes; 2) independence from laboratory animals; 3) rapidity, simplicity and low cost; 4) high volume throughput; 5) quantitative measure of receptor occupancy and efficacy; 6) adaptable to hundreds of receptors and subtypes.

Thesaurus Terms:
biomedical equipment development, fluorescence calcium ion, drug screening /evaluation

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----